Saturday 10 October 2026 Export all MODD data to Excel Powerpack

Modular Medical, Inc.

MODD Healthcare Medical Devices

In the quarter to June 2026, EPS grew 67.0% and free cash flow fell 5.61%, each against the same quarter a year earlier.

2.72 0.06 +2.26%
Market cap
$25.3M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '16
Current Ratio
4.03 10.69 6.66 4.13 9.68 0.50 4.82 36.72 278.29 0.00
Net Debt/EBITDA
0.27 0.73 0.54 0.28 0.70 0.20 0.59 2.56 6.47 (9.93)
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 (0.68)
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Operating CF/Net income
0.84 0.84 0.80 0.79 0.55 0.80 0.77 0.71 1.20 0.34
Capex/Depreciation
(2.35) (2.35) (3.99) (10.78) (0.03) (0.89) (7.37) (5.32) (8.05) —
Interest Coverage
— — — — — — — — — (1.47)
ROE
(188.05%) (131.58%) (210.34%) (199.51%) (492.82%) (920.35%) (113.79%) (47.06%) (31.96%) (1.51%)
ROA
(168.27%) (115.69%) (165.97%) (162.41%) (308.12%) (241.63%) (101.24%) (46.23%) (12.00%) 0.00%
ROIC
(286.27%) (298.97%) (475.71%) (679.23%) 0.00% 0.00% 0.00% 0.00% (1,867.15%) 0.00%
Return on Tangible Assets
(225.31%) (112.68%) (155.75%) (289.87%) (215.26%) 546.96% (188.27%) (39.27%) (15.29%) 16.05%
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% —
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% — —
Free Cash Flow per Share
(12.12) (14.77) (21.00) (31.39) (45.50) (29.10) (7.32) (3.41) (1.82) (0.03)
Cash per Share
3.04 10.62 12.39 9.43 40.04 7.10 5.25 11.86 9.68 0.00
Shareholders Equity per Share
5.67 13.85 15.48 12.60 38.98 (6.17) 4.84 11.72 9.73 (0.47)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
5.67 13.85 15.48 12.60 38.98 (6.17) 4.84 11.72 9.73 (0.47)
Free Cash Flow
(27.68) (18.21) (15.65) (12.65) (10.31) (6.02) (4.36) (1.88) (0.81) (0.01)
Working Capital
5.67 12.25 8.24 3.07 8.42 (1.65) 2.52 6.39 4.30 (0.19)
Capital Expenditures
(3.93) (2.49) (1.70) (1.64) (0.05) (0.11) (0.26) (0.08) (0.02) —
Net Current Asset Value
5.67 11.86 7.43 1.88 8.38 (1.87) 2.21 6.39 4.30 (0.19)
Other line items
Quick Ratio
3.71 10.35 6.35 3.88 9.36 0.45 4.72 36.63 277.21 0.00
Depreciation/Fixed assets
0.24 0.24 0.14 0.09 8.27 0.41 0.12 0.19 0.14 —
Cash ROIC
(139.11%) (60.36%) (75.37%) (142.52%) (57.58%) (3,111.89%) (72.59%) (14.47%) (9.36%) 17.07%
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Inventory Turnover
— — — 0.00 0.00 0.00 0.00 0.00 0.00 —
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
Days of Inventory on Hand
— — — 0.00 0.00 0.00 0.00 0.00 0.00 —
Revenue per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF per Share
(10.40) (12.75) (18.72) (27.32) (45.26) (28.57) (6.88) (3.27) (1.78) (0.03)
Capex per Share
(1.72) (2.02) (2.28) (4.06) (0.24) (0.53) (0.44) (0.14) (0.03) 0.00
Average Payables
0.67 0.57 0.54 0.29 0.23 0.27 0.25 0.08 — —
Average Assets
16.78 16.27 10.53 8.55 6.05 3.05 5.26 5.49 5.49 —
Average Common Equity
15.02 14.31 8.31 6.96 3.78 0.80 4.68 5.40 2.06 2.06
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —

Fold the line items

Columns are period end dates